Sero-epidemiology of transfusion-transmissible infectious diseases among blood donors in Osogbo, south-west Nigeria

Blood Transfusion

Volumn 7, Issue 4, 2009, Pages 293-299

  Buseri, Fiekumo Igbida ^a   Muhibi, Musa Abidemi ^b   Jeremiah, Zaccheaus Awortu ^a  

^a NIGER DELTA UNIVERSITY   (Nigeria)

^b LADOKE AKINTOLA UNIVERSITY OF TECHNOLOGY   (Nigeria)

Author keywords

Blood donors; Nigeria; Osogbo; Prevalence; Transfusion transmissible disease markers

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ADULT; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMAGGLUTINATION TEST; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN TISSUE; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; NIGERIA; SEROPREVALENCE; SYPHILIS;

ADOLESCENT; ADULT; ANTIBODIES, BACTERIAL; ANTIBODIES, VIRAL; BLOOD DONORS; BLOOD TRANSFUSION; BLOOD-BORNE PATHOGENS; FEMALE; HEPACIVIRUS; HEPATITIS B VIRUS; HEPATITIS C; HIV INFECTIONS; HIV-1; HIV-2; HUMANS; MALE; MIDDLE AGED; NIGERIA; PROSPECTIVE STUDIES; SEROEPIDEMIOLOGIC STUDIES; SYPHILIS; TREPONEMA PALLIDUM;

EID: 73449130880     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2009.0071-08     Document Type: Article

References (38)

1. World Health Organization (WHO). Blood Safety Strategy for the African Region. Brazzaville, World Health Organization, Regional Office for Africa (WHO AFR /RC51/9 Rev.1). 2002
2. World Health Organization (WHO). Status of blood safety in the WHO African Region: Report of the 2004 Survey WHO Regional Office for Africa, Brazzaville 2007: 1-25.
3. Kitchen AD, Barbara JAJ. Transfusion transmitted infections. In: Murphy MF and Pamphilon DH (Eds): Practical Transfusion Medicine. Blackwell Science, Oxford 2001: 192-210.
4. Holmberg J. Activities Relating to Global Blood Safety at the Department of Health and Human Services. USA. 2006: 1-5.
5. Burnouf T, Radesevich M. Reducing the risk of infection from plasma products: specific preventive strategies. Blood Rev 2000; 14: 94-110.
6. Choudhury N, Phadke S. Transfusion transmitted diseases. Indian J Paediatr 2001; 68: 951-8.
7. William A, Nicholas N, Ansah J, et al. Prevalence of blood borne infectious diseases in blood donors in Ghana. J Clin Microbiol 2002; 40: 3523-5.
8. Nwabuisi C, Aderinola CI, Ibegbulam OG. The seroprevalence of syphilis in unscreened and unstored blood transfused in Ilorin, Nigeria. Medipharm Med J 2005; 2:7-9.
9. Chukwurah EF, Nneli RO. Prevalence of transfusion transmissible infectious disease markers among blood donors in a south Eastern state of Nigeria. Niger Biomed Sci J 2005; 1: 114-7.
10. Baba MM, Hassan AW, Gashau W. Prevalence of hepatitis B antigenaemia and human immunodeficiency virus in blood donors in Maidugiri, Nigeria. Niger J Med 2000; 9: 10-2.
11. Mustapha SK, Jibrin YB. The prevalence of hepatitis B surface antigenaemia in patients with human immunodeficiency virus (HIV) infection in Gombe, Nigeria. Ann Afr Med 2004; 3: 10-2.
12. Ampofo W, Nil-Trebi N, Ansah J, et al. Prevalence of blood-borne infectious diseases in blood donors in Ghana. J Clin Microbiol 2002; 40: 3523-5.
13. Glynn SA, Kleinman SH, Schreiber. Trends in incidence and prevalence of major transfusion transmissible viral infection in the United States. J Am Med Assoc 2000; 284: 229-35.
14. Szmuness W, Much MI, Prince M, et al. Hepatitis B: evolving epidemiology and implications for control. Semin Liver Dis 1990; 11: 84-92.
15. Musi SS, Monny L M, Ndjitoyap NEC, et al. Prevalence of transfusion transmitted infectious agents among healthy blood donors in Cameroon. International Conference on AIDS Report. July 11-16; 2004: 15.
16. Amadi AN, Mba LE. Distribution of HIV infection in Abia State, Nigeria. Niger J Med Invest Pract 2001; 2:38-40.
17. Chikwem JO, Mohammed I, Okara GC, et al. Prevalence of transmissible blood infections among blood donors at the University of Maiduguri Teaching Hospital, Maiduguri, Nigeria. East Afr Med J 1997; 4: 213-6.
18. Adjei AA, Kudzi W, Armah H, et al. Prevalence of antibodies to syphilis among blood donors in Accra, Ghana. Japanese Infect Dis 2003; 56:165-7.
19. Ejele OA, Erhabor O, Nwauche CA. Trends in the prevalence of some transfusion-transmissible infections among blood donors in Port Harcourt, Nigeria. Haema 2005; 8: 273-7.
20. Rahlenbeck SI, Yohhanes G, Molla K, et al. Infection with HIV, syphilis and HBV in Ethiopia: a survey in blood donors. Int J STD/AIDS 1997; 8: 261-4.
21. Matee M, Magesa P, Lyamuya E. Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses and syphilis infections among blood donors at the Muhimbili National Hospital in Dar Es Salaam, Tanzania. BMC Public Health 2006: 6: 21-4.
22. Gardella C, Anthony A. Richard H, et al. Persons with early syphilis identified through blood or plasma donation screening in the United States. J Infect Dis 2002; 185:545-9.
23. Abbey SD, Erhabor O, Nwoka E, et al. Seroprevalence of Treponema pallidum infection among blood donors in a resource poor setting in the Niger Delta of Nigeria. Niger Biomed Sci J 2006; 2: 29-31.
24. Zohreh A, Mazyar G, Bashir H, et al. Zero prevalence of syphilis among blood donors in Tehran, Iran. Transfusion Today 2005; 64: 24.
25. Contreras M, Hewitt PE. Clinical blood transfusion. In: Hoffbrand AV, Lewis SM and Tuddenham (editors): Postgraduate Haematology. Fourth Edition. Arnold, London 2001: 215-34.
26. Egah DZ, Mandong BM, Iya D, et al. Hepatitis C virus antibodies among blood donors in Jos, Nigeria. Ann Afr Med 2004; 3: 35-7.
27. Mutimer D J, Olomu A, Skidmore S. Viral hepatitis in Nigeria - sickle cell disease and commercial blood donors. Quarterly J Med 1994; 87: 407-11.
28. Stevens CE, Taylor PE, Pindyck J. Epidemiology of hepatitis C virus. J Am Med Assoc 1997; 263: 49-53.
29. Sharara AI, Hunt CM , Hamilton JD. Hepatitis C. Ann Intern Med 1996; 125: 658-68.
30. Wansbrough-Jones MH, Frimpong E, Cant B, et al. Prevalence and genotype of hepatitis C virus infection in pregnant women and blood donors in Ghana. Trans R Soc Trop Med Hyg 1996; 92: 496-9.
31. Koate BBD, Buseri FI, Jeremiah ZA. Seroprevalence of hepatitis C virus among blood donors in Rivers State, Nigeria. Transfus Med 2005; 15: 449-51.
32. Halim NK, Ajayi OI. Risk factors and seroprevalence of hepatitis C antibody in blood donors in Nigeria. East Afr Med J 2000; 77: 410-12.
33. Rehman K, Khan AA, Haider Z, et al. Prevalence of serological 'markers of HBV and HCV in health care personnel and apparently healthy blood donors. J Pakistani Med Assoc 1996; 46: 152-4.
34. Jeremiah ZA, Koate B, Buseri F, et al. Prevalence of antibodies to hepatitis C virus in apparently healthy Port Harcourt donors and association with blood groups and other risk indicators. Blood Transfus 2008; 6: 150-5.
35. Ahsan SM, Mehta PR. HIV, HBV and HCV Coinfection Study. Bombay Hosp J 2002; 3:5-7.
36. Lodenyo H, Schoub B, Ailly R, et al. Hepatitis B and C virus infection and liver function in AIDS patients at Chris Hani Baragwanath Hospital, Johannesburg. East Afr Med J 2000; 77: 13-5.
37. Mustapha SK, Kudi AA, Asaka LE. Prevalence of hepatitis B surface antigen (HBsAg) and HIV among blood donors in Gombe. J Life Environ Sci 2002; 4: 231-5.
38. Busch MP, Glynn SA, Stramer SL, et al. Correlates of hepatitis C virus (HCV) RNA negativity among HCV seropositive blood donors. Transfusion 2006; 46: 469-75.